Form 4 for EYPT EyePoint, Inc.
Accepted 2024-04-02 00:00:00 ET · period of report 2024-03-30 · accession 0001562180-24-003193 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2024-04-02 | 2024-03-30 | EYPT | Paggiarino Dario A. | Chief Medical Off | M - OptEx | $0.00 | +50.4K | 48.1K | New | $0 |
| DM | 2024-04-02 | 2024-03-30 | EYPT | Paggiarino Dario A. | Chief Medical Off | F - Tax | $20.67 | -25.5K | 74.2K | -26% | -$528.0K |
| DM | 2024-04-02 | 2024-03-30 | EYPT | Paggiarino Dario A. | Chief Medical Off | M - OptEx | $0.00 | -50.4K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-03-30 | M | A | 14,000 | $0.00 | 92,626 | D | — | — | |
| 2 | Common | Common Stock | 2024-03-30 | M | A | 30,570 | $0.00 | 78,626 | D | — | — | |
| 3 | Common | Common Stock | 2024-03-30 | M | A | 5,834 | $0.00 | 48,056 | D | — | — | |
| 4 | Common | Common Stock | 2024-03-30 | F | D | 7,096 | $20.67 | 67,080 | D | — | — | |
| 5 | Common | Common Stock | 2024-03-30 | F | D | 15,493 | $20.67 | 77,133 | D | — | — | |
| 6 | Common | Common Stock | 2024-03-30 | F | D | 2,957 | $20.67 | 74,176 | D | — | — | |
| 7 | Derivative | Restricted Stock Units | 2024-03-30 | M | D | 14,000 | $0.00 | 0 | D | $0.00 · — to — | 14,000 Common Stock | (F4) The restricted stock units will vest in three ratable annual installments beginning January 5, 2025. |
| 8 | Derivative | Restricted Stock Units | 2024-03-30 | M | D | 5,834 | $0.00 | 0 | D | $0.00 · — to — | 5,834 Common Stock | (F3) The restricted stock units will vest in three ratable annual installments beginning February 9, 2023. |
| 9 | Derivative | Restricted Stock Units | 2024-03-30 | M | D | 30,570 | $0.00 | 0 | D | $0.00 · — to — | 30,570 Common Stock | (F2) The restricted stock units will vest in three ratable annual installments beginning January 6, 2024. |